GLP-1: A Mediator of the Beneficial Metabolic Effects of Bariatric Surgery?-Reference-Cited by-同舟云学术

GLP-1: A Mediator of the Beneficial Metabolic Effects of Bariatric Surgery?

Published:2015-01 Issue:1 Volume:30 Page:50-62
ISSN:1548-9213
Container-title:Physiology
language:en
Short-container-title:Physiology

Author:

Manning Sean¹²³,Pucci Andrea¹²,Batterham Rachel L.¹²³

Affiliation:

1. Department of Medicine, Centre for Obesity Research, Rayne Institute, University College London, London, United Kingdom;

2. UCLH Centre for Weight Loss, Metabolic and Endocrine Surgery, University College London Hospitals, London, United Kingdom;

3. National Institute of Health Research University College London Hospitals Biomedical Research Centre, London, United Kingdom

Abstract

There has been increasing interest in the role that gut hormones may play in contributing to the physiological changes produced by certain bariatric procedures, such as Roux-en-Y gastric bypass and sleeve gastrectomy. Here, we review the evidence implicating one such gut hormone, glucagon-like peptide-1, as a mediator of the metabolic benefits of these two procedures.

Publisher

American Physiological Society

Subject

Physiology

Link

https://www.physiology.org/doi/pdf/10.1152/physiol.00027.2014

Reference154 articles.

1. Preoperative Fasting Plasma C-Peptide Level May Help to Predict Diabetes Outcome After Gastric Bypass Surgery

2. Acute peripheral GLP-1 receptor agonism or antagonism does not alter energy expenditure in rats after Roux-en-Y gastric bypass

3. Recent advances in clinical practice challenges and opportunities in the management of obesity

5. Roux-en-Y gastric bypass normalizes the blunted postprandial bile acid excursion associated with obesity

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. G protein-coupled receptors driven intestinal glucagon-like peptide-1 reprogramming for obesity: Hope or hype?;Biomedicine & Pharmacotherapy;2024-03

2. Diagnosis and management of post-bariatric surgery hypoglycemia;Expert Review of Endocrinology & Metabolism;2023-10-18

3. Mechanism of metabolic surgery for the treatment of Type 2 Diabetes Mellitus (T2DM);Mini-invasive Surgery;2023-07-24

4. Optimal Small Bowel Limb Lengths of Roux-en-Y Gastric Bypass;Current Obesity Reports;2023-07-19

5. Postprandial hypoglycemia after ileocolic interposition and Billroth‐II gastrojejunostomy: A case report;Clinical Case Reports;2023-03